Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Causes of TIPS dysfunction Cura M; Cura A; Suri R; El-Merhi F; Lopera J; Kroma GAJR Am J Roentgenol 2008[Dec]; 191 (6): 1751-7OBJECTIVE: Transjugular intrahepatic portosystemic shunt (TIPS) creation is an effective method to control portal hypertension. TIPS creations with bare stents have shown limited and unpredictable patency. In nearly all cases of rebleeding or recurrent ascites after TIPS creation, there is shunt stenosis or occlusion. The purpose of this article is to review the biologic and technical factors that predispose to TIPS failure and how the use of an expandable polytetrafluoroethylene (PTFE)-covered-stent has significantly improved TIPS patency. CONCLUSION: Biologic and technical factors may predispose to shunt failure. The combination of improved technique and expandable PTFE has significantly improved TIPS patency. The need for follow-up venography and secondary interventions has been reduced significantly as a result of improved shunt patency.|Adult[MESH]|Ascites/diagnosis/*etiology[MESH]|Bile Ducts/*injuries[MESH]|Female[MESH]|Gastrointestinal Hemorrhage/*etiology[MESH]|Hepatic Veno-Occlusive Disease/diagnosis/*etiology[MESH]|Humans[MESH]|Hypertension, Portal/complications/*surgery[MESH]|Male[MESH]|Middle Aged[MESH]|Portasystemic Shunt, Transjugular Intrahepatic/*adverse effects[MESH]|Wounds, Penetrating/diagnosis/*etiology[MESH] |
